Live feed/
Filings
/
SCHEDULE 13D/A
/
0001213900-26-069783
Stake: 7.20%
Shares: 15,079,708
CUSIP: 63008G203
Class: Ordinary Shares, par value NIS 5.00 per share
Composite Decision Signal · PASS (LOW BASE-RATE EDGE)
Conviction Score: 39/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%
- Active Schedule 13D filer baseline
- Held by 1 tracked 13F institutional manager
- Elevated short days-to-cover (6.5 DTC)
Item 4 — Purpose of Transaction
Item 4 is hereby amended and supplemented as follows: "On June 15, 2026, the Issuer issued a press release announcing the signing of a term sheet with Infinite Epigenetics to form a publicly traded, AI-powered preventive health and diagnostics company (the "Proposed Transaction"). While the Reporting Person is evaluating all options available to it with respect to the Proposed Transaction, as an initial matter, the Reporting Person believes the Proposed Transaction is not in the best interests of the Issuer's shareholders and is strongly opposed to it."
Cross-References
Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
12 13D/G filings on this issuer
11 other filings besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 6.50
9,688,911 shares short · +1.5% vs prior
Institutional Consensus · 2025-12-31
Held by elite portfolio managers
1 holder · $40K
Point72 Asset Mgmt
Post-Filing Returns · since 2026-06-15 on NNDM
Anchor price 1.46 on closest trading day on/after 2026-06-15. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
Other 13D/G Filings on Nano Dimension Ltd.
| Filed | Form | Filer | Stake | Shares | |
|---|
| 2026-10-29 |
SCHEDULE 13D/A |
Murchinson Ltd. |
— |
20,416,500 |
view → |
| 2026-07-27 |
SCHEDULE 13D/A |
TANG CAPITAL MANAGEMENT LLC |
— |
16,715,812 |
view → |
| 2026-07-22 |
SCHEDULE 13D/A |
ORAMED PHARMACEUTICALS INC. |
— |
6,879,708 |
view → |
| 2026-07-20 |
SCHEDULE 13D/A |
Murchinson Ltd. |
— |
17,136,276 |
view → |
| 2026-06-30 |
SCHEDULE 13D |
TANG CAPITAL MANAGEMENT LLC |
— |
14,292,813 |
view → |
| 2026-06-23 |
SCHEDULE 13D/A |
Murchinson Ltd. |
— |
20,285,450 |
view → |
| 2026-05-21 |
SCHEDULE 13D/A |
Murchinson Ltd. |
7.40% |
15,550,000 |
view → |
| 2023-10-27 |
SC |
Murchinson Ltd. |
— |
— |
view → |
| 2023-05-02 |
SC |
Anson Funds Management LP |
— |
— |
view → |
| 2023-05-02 |
SC |
Murchinson Ltd. |
— |
— |
view → |
| 2021-12-14 |
SC |
STERN YOAV |
— |
— |
view → |
Other Filings by ORAMED PHARMACEUTICALS INC.
| Filed | Form | Issuer | Stake | Shares | |
|---|
| 2026-07-22 |
SCHEDULE 13D/A |
Nano Dimension Ltd. |
— |
6,879,708 |
view → |
| 2026-05-14 |
SCHEDULE 13D |
Lifeward Ltd. LFWD |
— |
1,528,221 |
view → |
Want this depth on every filing the moment it hits SEC EDGAR?
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →